IRIS - Res&Arch Institutional Research Information System - Research & Archive

AGNELLI, Giancarlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.537
EU - Europa 8.919
AS - Asia 2.969
SA - Sud America 17
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 2
Totale 24.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.464
UA - Ucraina 2.179
IE - Irlanda 2.146
IT - Italia 1.417
SG - Singapore 1.127
SE - Svezia 916
VN - Vietnam 681
FI - Finlandia 584
HK - Hong Kong 550
DE - Germania 522
RU - Federazione Russa 485
CN - Cina 345
GB - Regno Unito 223
TR - Turchia 147
FR - Francia 112
CH - Svizzera 76
CA - Canada 63
AT - Austria 51
BE - Belgio 45
NL - Olanda 37
UZ - Uzbekistan 35
LB - Libano 28
CZ - Repubblica Ceca 27
PL - Polonia 27
GR - Grecia 26
KR - Corea 24
BR - Brasile 11
EU - Europa 10
RO - Romania 8
SK - Slovacchia (Repubblica Slovacca) 8
EG - Egitto 7
JP - Giappone 6
MX - Messico 6
BG - Bulgaria 5
ES - Italia 5
IN - India 5
CL - Cile 4
HR - Croazia 4
IQ - Iraq 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BN - Brunei Darussalam 2
DK - Danimarca 2
EE - Estonia 2
LT - Lituania 2
LY - Libia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
AF - Afghanistan, Repubblica islamica di 1
AI - Anguilla 1
AM - Armenia 1
AZ - Azerbaigian 1
CR - Costa Rica 1
EC - Ecuador 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NG - Nigeria 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 24.468
Salva come PNG Salva come JPEG
Città #
Chandler 2.342
Dublin 2.139
San Mateo 1.222
Jacksonville 1.132
Singapore 821
Boardman 746
Dong Ket 681
Altamura 671
Santa Clara 612
Medford 576
Princeton 574
Hong Kong 548
Lawrence 501
Des Moines 485
Wilmington 395
Ann Arbor 383
Andover 360
Perugia 329
Ashburn 197
Saint Petersburg 174
Beijing 153
Izmir 144
Helsinki 112
Norwalk 112
San Paolo di Civitate 93
Los Angeles 87
Shanghai 75
Redmond 66
Rome 51
Brussels 45
Moscow 41
Woodbridge 39
Falls Church 36
Munich 35
Dearborn 34
Ottawa 34
Redwood City 29
Den Haag 25
New York 25
Houston 24
Seoul 23
Dallas 22
Auburn Hills 20
Amelia 16
Philadelphia 16
Hanover 14
Brno 13
Lausanne 13
Edinburgh 12
Frankfurt Am Main 12
Bareggio 10
Chicago 10
Toronto 10
Lappeenranta 9
Olomouc 9
Amsterdam 8
Bratislava 8
Vienna 8
Kiev 7
Seattle 7
London 6
Milan 6
Paris 6
Ponte 6
Buffalo 5
Clifton 5
Montreal 5
Cairo 4
Chengdu 4
Nürnberg 4
Parabiago 4
Secaucus 4
Simi Valley 4
Timisoara 4
Toledo 4
Zagreb 4
Ancona 3
Athens 3
Bologna 3
Faenza 3
Grottammare 3
Kocaeli 3
Pasadena 3
Phatthana Nikhom 3
Pioltello 3
San Diego 3
Sofia 3
Stockholm 3
Terni 3
Tokyo 3
Umbertide 3
Venice 3
Yorktown 3
Auckland 2
Bandar Seri Begawan 2
Belfiore 2
Belo Horizonte 2
Birmingham 2
Castello di Godego 2
Clearwater 2
Totale 16.535
Salva come PNG Salva come JPEG
Nome #
Epidemiology of cerebral vein and sinus thrombosis. 89
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 89
Secondary stroke prevention in women. 88
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. 87
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 87
Acute stroke symptoms: Do differences exist between sexes? 80
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter related deep vein thrombosis in a child with acute lymphoblastic leukemia 79
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 78
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 78
Risk factors for venous thromboembolism in the elderly: results of the master registry. 78
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 77
[Spinal anesthesia and prophylaxis of venous thromboembolism. Results of a national survey]. 77
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 77
Risk factor for upper limb deep vein thrombosis 76
Isolated monoparesis following stroke 76
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. 75
Vascular cognitive impairment: a pragmatic concept 74
Prevention of venous thromboembolism in surgical patients 74
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 74
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. 74
Gene-drug interaction in stroke. 73
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 72
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study 72
Early admission to stroke unit influences clinical outcome 72
Acute pulmonary embolism: risk stratification in the emergency department. 72
Aspirin for preventing the recurrence of venous thromboembolism. 71
Risk factors for adverse short-term outcome in patients with pulmonary embolism 70
Arterite temporale occulta: contributo casistico e revisione della letteratura 70
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 70
The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbits. 70
Spotlight: Giancarlo Agnelli, MD. Interview by Emma Baines. 70
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 70
Letter 3: Meta-analysis of trials comparing ximegatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery 69
Dermatan sulphate in patients with heparin-induced thrombocytopenia. 69
A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivo. 69
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 69
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 69
Thrombolysis in submassive pulmonary embolism 69
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. 68
Initial treatment of venous thromboembolism 68
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome. 68
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. 68
Current role of venography in the diagnosis of deep-vein thrombosis. 68
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 67
Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice. 67
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 67
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 66
Activation of blood coagulation in patients undergoing postoperative blood salvage and reinfusion of unwashed whole blood after total knee arthroplasty 66
A prospective study on cardiovascular events after acute pulmonary embolism 66
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. 66
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 66
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 66
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 66
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 65
Current issues in anticoagulation 65
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 65
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 65
Attitudes to prescribing compression stockings for patients with acute DVT: the MASTER registry. 65
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 64
New pharmacologic strategies for arterial and venous thromboembolism 64
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? 64
[Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. 64
Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy. 64
[Effect of platelet-derived growth factor on the in vitro cell proliferation of chick embryo skin]. 64
Anticoagulant agents in the management of pulmonary embolism. 64
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy 63
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 63
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 63
Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolism 63
Acute pulmonary embolism. 63
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 63
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 63
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 63
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 63
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 63
Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. 62
Antithrombotic therapy for venous thrombosis disease. 62
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 62
Prevention of venous thromboembolism in high risk patients. 62
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing 62
Combined oral anticoagulants and antiplatelets: benefits and risks. 61
Antithrombotic therapy for venous thromboembolic disease. 61
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. 61
Clinical outcome of orthopaedic patients with negative lower limb venography at discharge. 61
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. 61
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 61
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 61
Randomised double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers 61
Intravenous thrombolysis in acute myocardial infarction 60
Statins and stroke prevention. 60
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 60
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 60
Profilassi della trombosi venosa profonda in neurochirurgia 59
Outcome in patients with stroke associated with internal carotid artery occlusion 59
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. 59
What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? 59
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery. 59
Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. 59
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 59
Severity of acute intracerebral haemorrhage, elderly age and atrial fibrillation: Independent predictors of poor outcome at three months 59
Totale 6.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.435 0 0 0 0 319 33 327 53 367 171 44 121
2020/20214.241 19 341 94 337 1.438 141 249 36 424 96 334 732
2021/20224.446 53 780 64 153 232 31 46 1.540 68 167 469 843
2022/20238.339 663 1.638 121 542 651 1.170 21 340 2.832 23 264 74
2023/20242.458 205 309 189 40 47 22 475 123 164 119 427 338
2024/20252.035 52 714 151 240 878 0 0 0 0 0 0 0
Totale 25.471